The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling
Abstract
LC3-associated phagocytosis is a protective mechanism against inflammation, with antifibrogenic properties in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“activation of a noncanonical form of autophagy (LC3-associated phagocytosis) shifts the macrophage phenotype toward an anti-inflammatory stage with resulting antifibrogenic effects (133, 134)”
From Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy (2024) · doi:10.1146/annurev-pharmtox-020524-012013 · cites this paper as [134]
Citations
Cites
2 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 2×
“Rubicon is also a positive regulator of the phagocytic reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) complex, both by binding and stabilizing the phagocytic oxidase p22phox and by promoting assembly of the NOX2 complex (6, 7, 9, 10).”
BackgroundRetractedMartinez, J., Cunha, L. D., Park, S., Yang, M., Lu, Q., Orchard, R., Li, Q.-Z., Yan, M., Janke, L., Guy, C., et al. (2016) · Nature · doi:10.1038/nature17950 · Cited by 381 · cited 1×
“Last, the beneficial role of LAP in other human inflammatory disorders also merits further investigation, in light of our results in patients with cirrhosis, and those reported in mice for lupus erythematosus (40).”
ResultRetractedAMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 2×
“Sustained hepatic inflammation originating from monocytes/macrophages is crucial for progression of chronic liver diseases (1, 3).”
BackgroundToll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis
Sanjuan, M. A., Dillon, C. P., Tait, S. W. G., Moshiach, S., Dorsey, F., Connell, S., Komatsu, M., Tanaka, K., Cleveland, J. L., Withoff, S., et al. (2007) · Nature · doi:10.1038/nature06421 · Cited by 1,347 · cited 1×
“In contrast to autophagy, LAP proceeds independently of the preinitiation AMP-activated protein kinase–mammalian target of rapamycin–Unc-51 like autophagy activating kinase (AMPK/mTOR/ULK1) auto phagy activating kinase (ULK1) autophagy complex but nevertheless requires some autophagic components, such as the class III…”
BackgroundMatsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Maejima, I., Shirahama-Noda, K., Ichimura, T., Isobe, T., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1846 · Cited by 1,235
Petiot, A., Ogier-Denis, E., Blommaart, E. F. C., Meijer, A. J., & Codogno, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.992 · Cited by 1,164
Self-citationZhong, Y., Wang, Q. J., Li, X., Yan, Y., Backer, J. M., Chait, B. T., Heintz, N., & Yue, Z. (2009) · Nature Cell Biology · doi:10.1038/ncb1854 · Cited by 1,005
Properties of mouse and human IgG receptors and their contribution to disease models
Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 847 · cited 1×
“It is likely that this protection is mediated by endogenous mouse IgG binding to human FcRIIA, as it has been previously shown that all subclasses of mouse IgG can bind to human FcRIIA (36) and that mice with chronic liver injury, including chronic CCl4 administration, display hyperimmunoglobulinemia (37).”
BackgroundCB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Self-citation
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationAutophagy in inflammation, infection, and immunometabolism
Deretic, V. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.018 · Cited by 862
“, 2020) and antiinflammatory and anti-fiibrogenic activity in monocytes responding to liver injury (Wan et al., 2020).”
BackgroundWen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Machinery, regulation and pathophysiological implications of autophagosome maturation
Zhao, Y. G., Codogno, P., & Zhang, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00392-4 · Cited by 572
Self-citationMetabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metadata
- Authors
- Wan, J., Weiss, E., Ben Mkaddem, S., Mabire, M., Choinier, P.-M., Picq, O., Thibault-Sogorb, T., Hegde, P., Pishvaie, D., Bens, M., Broer, L., Gilgenkrantz, H., Moreau, R., Saveanu, L., Codogno, P., Monteiro, R. C., & Lotersztajn, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Université de Paris, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-75018 Paris, France.
- Hôpital Beaujon (FR)
- Corresponding author
- Wan, JingHong
- Weiss, Emmanuel
- Saveanu, Loredana
- Codogno, Patrice
- Monteiro, Renato C.
- Lotersztajn, Sophie
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-04-15
- Volume
- 12
- Issue
- 539
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3017134069
- Cited by
- 77
- References
- 45
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 17 · 2021: 18 · 2020: 6
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-18-CE14-0006)
- Fondation pour la Recherche Médicale (DEQ20150331726)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- LC3-associated phagocytosis, liver fibrosis, inflammation, Itami City, LAP, intravenous immunoglobulin, chronic liver disease, autophagy
- MeSH terms
- Animals, Humans, Inflammation, Liver Cirrhosis, Mice, Inbred C57BL, Microtubule-Associated Proteins, Phagocytosis, Signal Transduction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling. https://app.cochat.ai/papers/10.1126/scitranslmed.aaw8523
- The paper
- Wan, J., Weiss, E., Ben Mkaddem, S., Mabire, M., Choinier, P.-M., Picq, O., Thibault-Sogorb, T., Hegde, P., Pishvaie, D., Bens, M., Broer, L., Gilgenkrantz, H., Moreau, R., Saveanu, L., Codogno, P., Monteiro, R. C., & Lotersztajn, S. (2020). LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaw8523
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.